Doctor profile · Federal record
Dr. Miguel Perales, MD
Medical Oncology Physician (CMS: Medical Oncology) · New York, NY
- NPI 1922079839
- Accepts Medicare
- MIPS 74.0 / 100 · 2023
- 35 yrs in practice
- Male
- No sanctions
Practice & contact
- Primary practice
-
1275 York Ave
New York, NY 100216007
(646) 227-3813 - Mailing address
-
633 3Rd Ave, Box 3
New York, NY 100176706
Credentials & registration
- NPI registered
- January 2006 — 20 yrs on file
- Profile last updated
- July 8, 2007
- Year of graduation
- 1991 — 35 yrs since
- Specialty taxonomy
- 207RX0202X — NUCC code
- State license (1)
- New York #210675
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1922079839. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
258
Distinct HCPCS
3
Medicare allowed
$36,449
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99233 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 162 | 22 | $134 | |
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 84 | 31 | $161 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 12 | 11 | $110 |
In context: peer comparison
Among 122 peers in this city , average services per provider: 215. This provider delivers 1.2× the peer median.Open Payments
Industry payments received
All-time total
$95,009
Transactions
37
Manufacturers
12
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Gilead Sciences, Inc. | 18 | $34,340.98 | |
| SANOFI-AVENTIS U.S. LLC | 5 | $30,631.89 | |
| Merck Sharp & Dohme LLC | 2 | $10,370.00 | |
| E.R. Squibb & Sons, L.L.C. | 2 | $5,730.00 | |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $4,350.00 | |
| Novartis Pharmaceuticals Corporation | 1 | $3,200.00 | |
| Novartis Pharma AG | 2 | $2,042.61 | |
| CSL Behring | 1 | $1,950.00 | |
| BioNTech SE | 1 | $1,050.00 | |
| National Marrow Donor Program | 2 | $986.44 | |
| Pierre Fabre Pharmaceuticals, Inc. | 1 | $210.90 | |
| Kite Pharma, Inc. | 1 | $146.40 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
220
Patients
27
Total drug cost
$19,135
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Acyclovir | Generic | 79 | 27 | $2,740 |
| Tacrolimus | Generic | 48 | 0 | $2,096 |
| Sulfamethoxazole-Trimethoprim (Sulfamethoxazole/Trimethoprim) | Brand | 26 | 0 | $417 |
| Celecoxib | Generic | 24 | 0 | $361 |
| Atovaquone | Generic | 16 | 0 | $12,957 |
| Pantoprazole Sodium | Generic | 15 | 0 | $369 |
| Montelukast Sodium | Generic | 12 | 0 | $195 |
Frequently asked questions
What is Dr. Miguel Perales's medical specialty?
Dr. Miguel Perales practices Medical Oncology Physician in New York, NY.
Where does Dr. Miguel Perales practice?
Dr. Miguel Perales practices at 1275 York Ave, New York, NY 100216007. Office phone: 6462273813.
What is Dr. Miguel Perales's NPI?
Dr. Miguel Perales's National Provider Identifier (NPI) is 1922079839, issued by NPPES.
Does Dr. Miguel Perales accept Medicare assignment?
Yes. Dr. Miguel Perales accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Miguel Perales commonly perform?
Top Medicare-reported procedures in 2023: Subsequent hospital care with moderate levelof medical decision making (HCPCS 99233); Established patient office or other outpatient visit (HCPCS 99215); Established patient office or other outpatient visit (HCPCS 99214). Source: CMS Medicare Physician & Other Practitioners file.